ATE479682T1 - Kristalline form einer chinolin-carboxamid- verbindung - Google Patents

Kristalline form einer chinolin-carboxamid- verbindung

Info

Publication number
ATE479682T1
ATE479682T1 AT06740692T AT06740692T ATE479682T1 AT E479682 T1 ATE479682 T1 AT E479682T1 AT 06740692 T AT06740692 T AT 06740692T AT 06740692 T AT06740692 T AT 06740692T AT E479682 T1 ATE479682 T1 AT E479682T1
Authority
AT
Austria
Prior art keywords
quinoline
crystalline form
carboxamide compound
carboxamide
compound
Prior art date
Application number
AT06740692T
Other languages
English (en)
Inventor
Paul R Fatheree
S Derek Turner
Adam Goldblum
Robert Chao
Daniel Genov
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Application granted granted Critical
Publication of ATE479682T1 publication Critical patent/ATE479682T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT06740692T 2005-04-06 2006-04-05 Kristalline form einer chinolin-carboxamid- verbindung ATE479682T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66878005P 2005-04-06 2005-04-06
PCT/US2006/012978 WO2006108127A2 (en) 2005-04-06 2006-04-05 Crystalline form of a quinolinone-carboxamide compound

Publications (1)

Publication Number Publication Date
ATE479682T1 true ATE479682T1 (de) 2010-09-15

Family

ID=37074104

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06740692T ATE479682T1 (de) 2005-04-06 2006-04-05 Kristalline form einer chinolin-carboxamid- verbindung

Country Status (30)

Country Link
US (4) US7728004B2 (de)
EP (1) EP1874766B1 (de)
JP (2) JP5230407B2 (de)
KR (1) KR101322873B1 (de)
CN (1) CN101151264B (de)
AR (2) AR053208A1 (de)
AT (1) ATE479682T1 (de)
AU (1) AU2006232129B2 (de)
BR (1) BRPI0610657A2 (de)
CA (1) CA2603654C (de)
CY (1) CY1111275T1 (de)
DE (1) DE602006016586D1 (de)
DK (1) DK1874766T3 (de)
EA (1) EA012115B1 (de)
ES (1) ES2350495T3 (de)
HK (1) HK1110866A1 (de)
HR (1) HRP20100629T1 (de)
IL (1) IL186023A (de)
MA (1) MA29403B1 (de)
MX (1) MX2007012438A (de)
MY (1) MY151075A (de)
NO (1) NO339699B1 (de)
NZ (1) NZ561900A (de)
PE (1) PE20061310A1 (de)
PL (1) PL1874766T3 (de)
PT (1) PT1874766E (de)
SI (1) SI1874766T1 (de)
TW (1) TWI377206B (de)
WO (1) WO2006108127A2 (de)
ZA (1) ZA200708071B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7063671B2 (en) * 2002-06-21 2006-06-20 Boston Scientific Scimed, Inc. Electronically activated capture device
TWI351282B (en) * 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
DE602005014566D1 (de) 2004-11-05 2009-07-02 Theravance Inc Chinolinon-carboxamid-verbindungen
JP5086091B2 (ja) * 2004-11-05 2012-11-28 セラヴァンス， インコーポレーテッド ５−ｈｔ４受容体アゴニスト化合物
TWI377206B (en) * 2005-04-06 2012-11-21 Theravance Inc Crystalline form of a quinolinone-carboxamide compound
EP3696174A1 (de) 2005-11-08 2020-08-19 Vertex Pharmaceuticals Incorporated Heterocyclische modulatoren von atp-bindenden kassettentransportern
JP2010527357A (ja) * 2007-05-17 2010-08-12 セラヴァンス， インコーポレーテッド 腸の前処置のための運動促進剤
CH698729B1 (de) * 2007-05-30 2009-10-15 Cerbios Pharma Sa Stabile, kristalline (6S)-N(5)-Methyl-5, 6,7,8-tetrahydrofolsäure.
CN103626744B (zh) * 2007-12-07 2016-05-11 沃泰克斯药物股份有限公司 3-(6-(1-(2,2-二氟苯并[d][1,3]间二氧杂环戊烯-5-基)环丙烷甲酰氨基)-3-甲基吡啶-2-基)苯甲酸的固体形式
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
PT2419104T (pt) * 2009-04-13 2018-01-31 Theravance Biopharma R&D Ip Llc Combinações de agonistas do recetor 5-ht4 e inibidores da acetilcolinesterase para o tratamento de distúrbios cognitivos
WO2011092293A2 (en) 2010-02-01 2011-08-04 Novartis Ag Cyclohexyl amide derivatives as crf receptor antagonists
WO2011092290A1 (en) 2010-02-01 2011-08-04 Novartis Ag Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
EP2531490B1 (de) 2010-02-02 2014-10-15 Novartis AG Cyclohexylamidderivate als crf-rezeptorantagonisten
WO2011127241A2 (en) 2010-04-07 2011-10-13 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof
KR102280372B1 (ko) 2013-11-12 2021-07-22 버텍스 파마슈티칼스 인코포레이티드 Cftr 매개된 질환 치료용 약제학적 조성물의 제조 방법
JP7431721B2 (ja) * 2017-07-31 2024-02-15 セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー ベルセトラグを用いて胃不全麻痺の症状を治療する方法
WO2024061960A1 (en) 2022-09-20 2024-03-28 Alfasigma S.P.A. Velusetrag for use in the treatment of chronic intestinal pseudo-obstruction (cipo)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3122671B2 (ja) 1990-05-23 2001-01-09 協和醗酵工業株式会社 複素環式化合物
DE69113284T2 (de) * 1990-12-28 1996-02-22 Kyowa Hakko Kogyo Kk Chinolinderivat.
AU5161593A (en) 1992-11-20 1994-06-22 Taisho Pharmaceutical Co., Ltd. Heterocyclic compound
JP3829879B2 (ja) 1994-05-18 2006-10-04 大正製薬株式会社 キノリンカルボン酸誘導体
TW402591B (en) * 1997-07-11 2000-08-21 Janssen Pharmaceutica Nv Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
US7105195B2 (en) * 2003-07-25 2006-09-12 General Mills, Inc. Reduced trans fat product
ES2338882T3 (es) 2003-11-24 2010-05-13 Pfizer, Inc. Compuestos de acido quinolona-carboxilico que tienen actividad agonista del receptor 5-ht4.
US7728006B2 (en) 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
JP5086091B2 (ja) 2004-11-05 2012-11-28 セラヴァンス， インコーポレーテッド ５−ｈｔ４受容体アゴニスト化合物
DE602005014566D1 (de) 2004-11-05 2009-07-02 Theravance Inc Chinolinon-carboxamid-verbindungen
TW200640921A (en) 2005-02-17 2006-12-01 Theravance Inc Crystalline form of an indazole-carboxamide compound
EP1871772B1 (de) 2005-03-02 2014-09-10 Theravance, Inc. Chinolinverbindungen als agonisten des 5-ht4-rezeptors
TWI377206B (en) * 2005-04-06 2012-11-21 Theravance Inc Crystalline form of a quinolinone-carboxamide compound

Also Published As

Publication number Publication date
NO339699B1 (no) 2017-01-23
ZA200708071B (en) 2008-10-29
PT1874766E (pt) 2010-11-30
US8658671B2 (en) 2014-02-25
US9402840B2 (en) 2016-08-02
TW200643020A (en) 2006-12-16
ES2350495T3 (es) 2011-01-24
DK1874766T3 (da) 2010-12-06
EP1874766B1 (de) 2010-09-01
AR053208A1 (es) 2007-04-25
MY151075A (en) 2014-03-31
WO2006108127A2 (en) 2006-10-12
US20100197728A1 (en) 2010-08-05
JP2008535848A (ja) 2008-09-04
CN101151264A (zh) 2008-03-26
CN101151264B (zh) 2011-07-06
US7728004B2 (en) 2010-06-01
AR110019A2 (es) 2019-02-13
NO20075574L (no) 2007-11-02
EP1874766A2 (de) 2008-01-09
KR101322873B1 (ko) 2013-10-30
US20160095849A1 (en) 2016-04-07
WO2006108127A3 (en) 2007-01-04
JP5230407B2 (ja) 2013-07-10
EA200702161A1 (ru) 2008-04-28
PL1874766T3 (pl) 2011-02-28
EA012115B1 (ru) 2009-08-28
CA2603654C (en) 2014-05-27
MX2007012438A (es) 2007-12-05
AU2006232129B2 (en) 2012-07-12
CA2603654A1 (en) 2006-10-12
CY1111275T1 (el) 2015-08-05
US20060229332A1 (en) 2006-10-12
JP2012153725A (ja) 2012-08-16
MA29403B1 (fr) 2008-04-01
DE602006016586D1 (de) 2010-10-14
PE20061310A1 (es) 2007-01-23
TWI377206B (en) 2012-11-21
HRP20100629T1 (hr) 2010-12-31
BRPI0610657A2 (pt) 2010-07-13
IL186023A (en) 2011-09-27
AU2006232129A1 (en) 2006-10-12
KR20070116988A (ko) 2007-12-11
IL186023A0 (en) 2008-01-20
US20140256769A1 (en) 2014-09-11
US9126994B2 (en) 2015-09-08
HK1110866A1 (en) 2008-07-25
NZ561900A (en) 2010-12-24
SI1874766T1 (sl) 2010-12-31

Similar Documents

Publication Publication Date Title
ATE479682T1 (de) Kristalline form einer chinolin-carboxamid- verbindung
LTC2004635I2 (lt) Pakeistieji enaminokarbonilo junginiai
LTC2343304I2 (lt) Biocidiniai boronoftalido junginiai
ATE449762T1 (de) Kristalline formen einer biphenylverbindung
DK1778672T3 (da) Krystallinsk form af en biphenylforbindelse
ATE520660T1 (de) Kristalline formen einer dimethylphenylverbindung
DK3061467T3 (da) Sårforbinding med en bakterieadsorberende sammensætning
DE602006017080D1 (de) Einer verpackung
ATE521238T1 (de) Kristalline modifikationen des pyraclostrobins
GB0504995D0 (en) Use of a compound
FI20055616A0 (fi) Menetelmä valmisteen rakenteen muokkaamiseen
DE602006002201D1 (de) Befestigungsanordung einer Fahrradleuchte
BRPI0814801A2 (pt) composto de piridazina cristalina
ATE443056T1 (de) Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen
DE602006020758D1 (de) Längslenker einer aufhängung
ATE513470T1 (de) Kristalline fipronil-modifikation
DE602006017324D1 (de) Zusammensetzung einer Nickel-Basis-Superlegierung
ITMI20050680A1 (it) Nuovi composti anti-infiammatori
DK1877403T3 (da) Mono-lysinsalte af azolforbindelser
IL187981A0 (en) Crystalline forms of a pyrrolotriazine compound
BRPI0922920A2 (pt) formas cristalinas de um composto de 3-carboxipropil-aminotetralina
ITMI20042437A1 (it) Forma cristallina di rabeprazolo sodico
BRPI0610721A2 (pt) processo para a preparação de um composto
DE102006003589B8 (de) Sumpf einer Geschirrspülmaschine
BRPI0820430A2 (pt) Composto

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1874766

Country of ref document: EP